Philippe Gallay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hepion Pharmaceuticals (HEPA) Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model

Hepion Pharmaceuticals (HEPA) Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert fosterPhilippe gallayWinston staufferScripps research institute la jollaHepion pharmaceuticals incHepion pharmaceuticalsArtificial intelligenceScripps research instituteDaren ureChief scientificCyclophilin inhibitor rencofilstat decreasesInduced carcinoma independentlyIts antiviral

Hepion Pharmaceuticals to Present Two Posters at EASL International Liver Congress™ 2023

Hepion Pharmaceuticals to Present Two Posters at EASL International Liver Congress™ 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert fosterWinston staufferPatrick mayoPhilippe gallayBhavesh variyaLacey haddonHepion pharmaceuticals incDrug administrationHepion pharmaceuticalsStephen kilmerhepion pharmaceuticals investor relationsdirectScripps research institute winston staufferInternational liver congressHepion pharmaceuticals researchScripps researchExchange commission

Enochian BioSciences, Inc : Scientific Leaders Agree on Promise of Enochian BioSciences

LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) (NASDAQ: ENOB) - Enochian BioSciences is working to solve our greatest public health threats like HIV, cancer, and coronavirus. The company's underlying scientific

Enochian bioscienceAnahid jewettPhilippe gallayEnochian biosciencesScripps researchPediatrics of the university alabamaErich whitleyDistinguished professorLoeb eminent scholar chairRespiratory diseases scientific advisory boardAnnual report

Active agent in Australian-developed nasal spray >99 5% active against the Omicron SARS-CoV-2 variant

The antiviral agent in VIRALEZE™ antiviral nasal spray, SPL7013, achieved >99.5% reduction of virus infectivity (the maximal possible reduction) against.

Republic ofSaudi arabiaUnited statesNew zealandJackie fairleyPhilippe gallayScripps research instituteScripps researchProfessor philippe gallayOpportunistic infectionsAbstracts from

New Nasal Spray Claims to Reduce CCP Virus Infectivity by Over 99 Percent in 30 Seconds: Scripps Research Institute

New Nasal Spray Claims to Reduce CCP Virus Infectivity by Over 99 Percent in 30 Seconds: Scripps Research Institute
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

United statesCraig kellyJackie fairleyGreg huntPhilippe gallayScripps research instituteAustralia therapeutic goods administrationChinese communist partyFederal health minister greg huntEpoch timesTherapeutic goods administrationஒன்றுபட்டது மாநிலங்களில்கிரேக் கெல்லிஜாக்கி ஃபேர்லிகிரெக் வேட்டைஸ்கிரிப்ட்கள் ஆராய்ச்சி நிறுவனம்